Anti-SLC33A1 monoclonal antibody

Pre-made anti-SLC33A1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC33A1/SLC33A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0002-Ab-1/ GM-Tg-hg-IP0002-Ab-2Anti-Human SLC33A1 monoclonal antibodyHuman
GM-Tg-rg-IP0002-Ab-1/ GM-Tg-rg-IP0002-Ab-2Anti-Rat SLC33A1 monoclonal antibodyRat
GM-Tg-mg-IP0002-Ab-1/ GM-Tg-mg-IP0002-Ab-2Anti-Mouse SLC33A1 monoclonal antibodyMouse
GM-Tg-cynog-IP0002-Ab-1/ GM-Tg-cynog-IP0002-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC33A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0002-Ab-1/ GM-Tg-felg-IP0002-Ab-2Anti-Feline SLC33A1 monoclonal antibodyFeline
GM-Tg-cang-IP0002-Ab-1/ GM-Tg-cang-IP0002-Ab-2Anti-Canine SLC33A1 monoclonal antibodyCanine
GM-Tg-bovg-IP0002-Ab-1/ GM-Tg-bovg-IP0002-Ab-2Anti-Bovine SLC33A1 monoclonal antibodyBovine
GM-Tg-equg-IP0002-Ab-1/ GM-Tg-equg-IP0002-Ab-2Anti-Equine SLC33A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0002-Ab-1/ GM-Tg-hg-IP0002-Ab-2; GM-Tg-rg-IP0002-Ab-1/ GM-Tg-rg-IP0002-Ab-2;
GM-Tg-mg-IP0002-Ab-1/ GM-Tg-mg-IP0002-Ab-2; GM-Tg-cynog-IP0002-Ab-1/ GM-Tg-cynog-IP0002-Ab-2;
GM-Tg-felg-IP0002-Ab-1/ GM-Tg-felg-IP0002-Ab-2; GM-Tg-cang-IP0002-Ab-1/ GM-Tg-cang-IP0002-Ab-2;
GM-Tg-bovg-IP0002-Ab-1/ GM-Tg-bovg-IP0002-Ab-2; GM-Tg-equg-IP0002-Ab-1/ GM-Tg-equg-IP0002-Ab-2
Products NameAnti-SLC33A1 monoclonal antibody
Formatmab
Target NameSLC33A1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC33A1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0002-Ag-1Recombinant multi-species ACATN/ SLC33A1/ AT-1 protein
    ORF Viral VectorpGMLP004379human SLC33A1 Lentivirus plasmid
    ORF Viral VectorvGMLP004379human SLC33A1 Lentivirus particle
    ORF Viral VectorpGMLPm005442mouse Slc33a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm005442mouse Slc33a1 Lentivirus particle


    Target information

    Target IDGM-IP0002
    Target NameSLC33A1
    Gene ID9197,11416,64018,721420,485724,101086745,517797,100051998
    Gene Symbol and SynonymsACATN,AT-1,AT1,CCHLND,D630022N01Rik,SLC33A1,SPG42
    Uniprot AccessionO00400,Q6AYY8
    Uniprot Entry NameACATN_HUMAN,ACATN_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseBreast Cancer
    Gene EnsemblENSG00000169359
    Target ClassificationN/A

    The target: SLC33A1, gene name: SLC33A1, also named as ACATN, AT-1, AT1, CCHLND, SPG42. The protein encoded by this gene is required for the formation of O-acetylated (Ac) gangliosides. The encoded protein is predicted to contain 6 to 10 transmembrane domains, and a leucine zipper motif in transmembrane domain III. Defects in this gene have been reported to cause spastic paraplegia autosomal dominant type 42 (SPG42) in one Chinese family, but not in similar patients of European descent. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.